DDAVP/Desmopressin 0.1mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

ddavp/desmopressin 0.1mg tablets

ferring ireland ltd - desmopressin acetate - tablet - 0.1 milligram(s) - vasopressin and analogues; desmopressin

Desmopressin-PH&T New Zealand - English - Medsafe (Medicines Safety Authority)

desmopressin-ph&t

aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.1mg equivalent to desmopressin 0.0890 mg;   - tablet - 100 mcg - active: desmopressin acetate trihydrate 0.1mg equivalent to desmopressin 0.0890 mg   excipient: lactose monohydrate magnesium stearate maize starch povidone

Desmopressin-PH&T New Zealand - English - Medsafe (Medicines Safety Authority)

desmopressin-ph&t

aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.2mg equivalent to desmopressin 0.178 mg;   - tablet - 200 mcg - active: desmopressin acetate trihydrate 0.2mg equivalent to desmopressin 0.178 mg   excipient: lactose monohydrate magnesium stearate maize starch povidone

Desmopressin-PH&T New Zealand - English - Medsafe (Medicines Safety Authority)

desmopressin-ph&t

aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.6mg equivalent to desmopressin 0.089 mg/ml;   - nasal spray solution - 0.1 mg/ml - active: desmopressin acetate trihydrate 0.6mg equivalent to desmopressin 0.089 mg/ml   excipient: chlorobutanol hemihydrate hydrochloric acid nitrogen purified water sodium chloride

DESMOPRESSIN TEVA 0.1 MG Israel - English - Ministry of Health

desmopressin teva 0.1 mg

teva israel ltd - desmopressin acetate - tablets - desmopressin acetate 0.1 mg - desmopressin - desmopressin - desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. the treatment must be started befor the age of 65.

DESMOPRESSIN TEVA 0.2 MG Israel - English - Ministry of Health

desmopressin teva 0.2 mg

teva israel ltd - desmopressin acetate - tablets - desmopressin acetate 0.2 mg - desmopressin - desmopressin - desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. the treatment must be started befor the age of 65.

MINIRIN TABLETS 0.1 MG Israel - English - Ministry of Health

minirin tablets 0.1 mg

ferring pharmaceuticals ltd - desmopressin acetate - tablets - desmopressin acetate 0.1 mg - desmopressin - desmopressin - central diabetes insipidus.nocturnal enuresis. treatment of nocturia in adults associated with nocturnal polyuria.

DESMOPRESSIN ACETATE- desmopressin acetate tablet United States - English - NLM (National Library of Medicine)

desmopressin acetate- desmopressin acetate tablet

impax generics - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.1 mg - desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablets. desmopressin a

DESMOPRESSIN ACETATE tablet United States - English - NLM (National Library of Medicine)

desmopressin acetate tablet

bluepoint laboratories - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.1 mg - desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate tablets are ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate tablets may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablet

DESMOPRESSIN ACETATE- desmopressin acetate tablet United States - English - NLM (National Library of Medicine)

desmopressin acetate- desmopressin acetate tablet

ncs healthcare of ky, inc dba vangard labs - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.2 mg - desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablets. desmopressin a